Cover Image
Market Research Report
Product code 
980309

Hydroxychloroquine Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Published: | Transparency Market Research | 135 Pages | Delivery time: 1-2 business days

Price

Back to Top
Hydroxychloroquine Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030
Published: November 27, 2020
Transparency Market Research
Content info: 135 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

Title:
Hydroxychloroquine Drugs Market (Disease Indication: Malaria, Rheumatoid Arthritis, COVID-19, Systemic Lupus Erythematosus, and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030.

Hydroxychloroquine Drugs Market - Scope of the Report

TMR's report on the global hydroxychloroquine drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global hydroxychloroquine drugs market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hydroxychloroquine drugs market from 2020 to 2030.

The report has been prepared after extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global hydroxychloroquine drugs market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various attributes of the global hydroxychloroquine drugs market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global hydroxychloroquine drugs market. These serve as valuable tools for existing market players as well as entities interested in participating in the global hydroxychloroquine drugs market.

The report also delves into the competition landscape of the global hydroxychloroquine drugs market. Key players operating in the global hydroxychloroquine drugs market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global hydroxychloroquine drugs market that have been profiled in this report.

Key Questions Answered in Hydroxychloroquine Drugs Report

What is the sales/revenue generated by hydroxychloroquine drug providers across all regions during the forecast period?

What are the opportunities in the global hydroxychloroquine drugs market?

What are the major drivers, restraints, and threats in the global market?

Which region is set to expand at the fastest CAGR during the forecast period?

Which distribution channel segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?

What are the market positions of different companies operating in the global market?

Hydroxychloroquine Drugs Market - Research Objectives and Research Approach

The comprehensive report on the global hydroxychloroquine drugs market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of distribution channels.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that have been appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global hydroxychloroquine drugs market in terms of disease indication, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders to make informed business decisions for investment in the global hydroxychloroquine drugs market.

Product Code: TMRGL76910

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Hydroxychloroquine Drugs Market

4. Market Overview

  • 4.1. Introduction & Overview
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
  • 4.3. Global Hydroxychloroquine Drugs Market Analysis and Forecast, 2018-2030

5. Market Outlook

  • 5.1. COVID-19 Pandemics Impact on Industry
  • 5.2. Regulatory Scenario by Region/globally
  • 5.3. Disease Prevalence & Incidence Rate globally with key countries

6. Global Hydroxychloroquine Drugs Market Analysis and Forecast, by Disease Indication

  • 6.1. Introduction & Definition
  • 6.2. Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018-2030
    • 6.2.1. Malaria
    • 6.2.2. Rheumatoid Arthritis
    • 6.2.3. COVID-19
    • 6.2.4. Systemic Lupus Erythematosus
    • 6.2.5. Others
  • 6.3. Global Hydroxychloroquine Drugs Market Attractiveness Analysis, by Disease Indication

7. Global Hydroxychloroquine Drugs Market Analysis and Forecast, by Distribution Channel

  • 7.1. Introduction & Definition
  • 7.2. Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 7.2.1. Hospital Pharmacies
    • 7.2.2. Retail Pharmacies
    • 7.2.3. Online Pharmacies
  • 7.3. Global Hydroxychloroquine Drugs Market Attractiveness Analysis, by Distribution Channel

8. Global Hydroxychloroquine Drugs Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Global Hydroxychloroquine Drugs Market Attractiveness Analysis, by Region

9. North America Hydroxychloroquine Drugs Market Analysis and Forecast

  • 9.1. Introduction
  • 9.2. North America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018-2030
    • 9.2.1. Malaria
    • 9.2.2. Rheumatoid Arthritis
    • 9.2.3. COVID-19
    • 9.2.4. Systemic Lupus Erythematosus
    • 9.2.5. Others
  • 9.3. North America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail Pharmacies
    • 9.3.3. Online Pharmacies
  • 9.4. North America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country, 2018-2030
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. North America Hydroxychloroquine Drugs Market Attractiveness Analysis
    • 9.5.1. By Disease Indication
    • 9.5.2. By Distribution Channel
    • 9.5.3. By Country

10. Europe Hydroxychloroquine Drugs Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Europe Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018-2030
    • 10.2.1. Malaria
    • 10.2.2. Rheumatoid Arthritis
    • 10.2.3. COVID-19
    • 10.2.4. Systemic Lupus Erythematosus
    • 10.2.5. Others
  • 10.3. Europe Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. Online Pharmacies
  • 10.4. Europe Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Europe Hydroxychloroquine Drugs Market Attractiveness Analysis
    • 10.5.1. By Disease Indication
    • 10.5.2. By Distribution Channel
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Hydroxychloroquine Drugs Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Asia Pacific Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018-2030
    • 11.2.1. Malaria
    • 11.2.2. Rheumatoid Arthritis
    • 11.2.3. COVID-19
    • 11.2.4. Systemic Lupus Erythematosus
    • 11.2.5. Others
  • 11.3. Asia Pacific Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 11.3.1. Hospital Pharmacies
    • 11.3.2. Retail Pharmacies
    • 11.3.3. Online Pharmacies
  • 11.4. Asia Pacific Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Asia Pacific Hydroxychloroquine Drugs Market Attractiveness Analysis
    • 11.5.1. By Disease Indication
    • 11.5.2. By Distribution Channel
    • 11.5.3. By Country/Sub-region

12. Latin America Hydroxychloroquine Drugs Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Latin America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018-2030
    • 12.2.1. Malaria
    • 12.2.2. Rheumatoid Arthritis
    • 12.2.3. COVID-19
    • 12.2.4. Systemic Lupus Erythematosus
    • 12.2.5. Others
  • 12.3. Latin America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 12.3.1. Hospital Pharmacies
    • 12.3.2. Retail Pharmacies
    • 12.3.3. Online Pharmacies
  • 12.4. Latin America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Latin America Hydroxychloroquine Drugs Market Attractiveness Analysis
    • 12.5.1. By Disease Indication
    • 12.5.2. By Distribution Channel
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Hydroxychloroquine Drugs Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Middle East & Africa Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018-2030
    • 13.2.1. Malaria
    • 13.2.2. Rheumatoid Arthritis
    • 13.2.3. COVID-19
    • 13.2.4. Systemic Lupus Erythematosus
    • 13.2.5. Others
  • 13.3. Middle East & Africa Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 13.3.1. Hospital Pharmacies
    • 13.3.2. Retail Pharmacies
    • 13.3.3. Online Pharmacies
  • 13.4. Middle East & Africa Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Middle East & Africa Hydroxychloroquine Drugs Market Attractiveness Analysis
    • 13.5.1. By Disease Indication
    • 13.5.2. By Distribution Channel
    • 13.5.3. By Country/Sub-region

14. Competitive Landscape

  • 14.1. Market Position Analysis, by Company, 2019
  • 14.2. Company Profiles
    • 14.2.1. Sanofi
      • 14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.1.2. Growth Strategies
      • 14.2.1.3. SWOT Analysis
    • 14.2.2. Amneal Pharmaceuticals, Inc.
      • 14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.2.2. Growth Strategies
      • 14.2.2.3. SWOT Analysis
    • 14.2.3. Mylan N.V.
      • 14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.3.2. Growth Strategies
      • 14.2.3.3. SWOT Analysis
    • 14.2.4. Teva Pharmaceutical Industries Ltd.
      • 14.2.4.1. Company Overview (HQ, Business Segments)
      • 14.2.4.2. Growth Strategies
      • 14.2.4.3. SWOT Analysis
    • 14.2.5. Novartis AG
      • 14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.5.2. Growth Strategies
      • 14.2.5.3. SWOT Analysis
    • 14.2.6. Zydus Cadila
      • 14.2.6.1. Company Overview (HQ, Business Segments)
      • 14.2.6.2. Growth Strategies
      • 14.2.6.3. SWOT Analysis
    • 14.2.7. Dr. Reddy's Laboratories Ltd.
      • 14.2.7.1. Company Overview (HQ, Business Segments)
      • 14.2.7.2. Growth Strategies
      • 14.2.7.3. SWOT Analysis
    • 14.2.8. Sun Pharmaceutical Industries Ltd.
      • 14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.8.2. Growth Strategies
      • 14.2.8.3. SWOT Analysis
    • 14.2.9. Lupin Limited
      • 14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.9.2. Growth Strategies
      • 14.2.9.3. SWOT Analysis
    • 14.2.10. Prasco Laboratories
      • 14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.2.10.2. Company Financials
      • 14.2.10.3. Growth Strategies
      • 14.2.10.4. SWOT Analysis

List of Tables

  • Table 01: Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Disease Indication, 2018-2030
  • Table 02: Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 03: Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Region, 2018-2030
  • Table 04: North America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Country, 2018-2030
  • Table 05: North America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2018-2030
  • Table 06: North America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 07: Europe Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 08: Europe Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2018-2030
  • Table 09: Europe Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 10: Asia Pacific Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 11: Asia Pacific Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2018-2030
  • Table 12: Asia Pacific Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 13: Latin America Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 14: Latin America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2018-2030
  • Table 15: Latin America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 16: Middle East & Africa Remote Patient Monitoring Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 17: Middle East & Africa Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2018-2030
  • Table 18: Middle East & Africa Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018-2030

List of Figures

  • Figure 1: Global Hydroxychloroquine Drugs Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 2: Global Hydroxychloroquine Drugs Market Value Share, by Disease Indication, 2019
  • Figure 3: Global Hydroxychloroquine Drugs Market Value Share, by Distribution Channel, 2019
  • Figure 4: Global Hydroxychloroquine Drugs Market Value Share Analysis, by Disease Indication, 2019 and 2030
  • Figure 5: Global Hydroxychloroquine Drugs Market Attractiveness Analysis, by Disease Indication, 2020-2030
  • Figure 6: Global Hydroxychloroquine Drugs Market Revenue (US$ Mn), by Malaria, 2018-2030
  • Figure 7: Global Hydroxychloroquine Drugs Market Revenue (US$ Mn), by Rheumatoid Arthritis, 2018-2030
  • Figure 8: Global Hydroxychloroquine Drugs Market Revenue (US$ Mn), by COVID-19, 2018-2030
  • Figure 9: Global Hydroxychloroquine Drugs Market Revenue (US$ Mn), by Systemic Lupus Erythematosus, 2018-2030
  • Figure 10: Global Hydroxychloroquine Drugs Market Revenue (US$ Mn), by Others, 2018-2030
  • Figure 11: Global Hydroxychloroquine Drugs Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 12: Global Hydroxychloroquine Drugs Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 13: Global Hydroxychloroquine Drugs Market Revenue (US$ Mn), by Hospital Pharmacies, 2018-2030
  • Figure 14: Global Hydroxychloroquine Drugs Market Revenue (US$ Mn), by Retail Pharmacies, 2018-2030
  • Figure 15: Global Hydroxychloroquine Drugs Market Revenue (US$ Mn), by Online Pharmacies, 2018-2030
  • Figure 16: Global Hydroxychloroquine Drugs Market Value Share Analysis, by Region, 2019 and 2030
  • Figure 17: Global Hydroxychloroquine Drugs Market Attractiveness Analysis, by Region, 2020-2030
  • Figure 18: North America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 19: North America Hydroxychloroquine Drugs Market Value Share (%), by Country, 2019 and 2030
  • Figure 20: North America Hydroxychloroquine Drugs Market Attractiveness, by Country, 2020-2030
  • Figure 21: North America Hydroxychloroquine Drugs Market Value Share (%), by Disease Indication, 2019 and 2030
  • Figure 22: North America Hydroxychloroquine Drugs Market Attractiveness, by Disease Indication, 2020-2030
  • Figure 23: North America Hydroxychloroquine Drugs Market Value Share (%), by Distribution Channel, 2019 and 2030
  • Figure 24: North America Hydroxychloroquine Drugs Market Attractiveness, by Distribution Channel, 2020-2030
  • Figure 25: Europe Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 26: Europe Hydroxychloroquine Drugs Market Value Share, by Country/Sub-region, 2019-2030
  • Figure 27: Europe Hydroxychloroquine Drugs Market Attractiveness, by Country/Sub-region, 2019-2030
  • Figure 28: Europe Hydroxychloroquine Drugs Market Value Share (%), by Disease Indication, 2019 and 2030
  • Figure 29: Europe Hydroxychloroquine Drugs Market Attractiveness, by Disease Indication, 2020-2030
  • Figure 30: Europe Hydroxychloroquine Drugs Market Value Share (%), by Distribution Channel, 2019 and 2030
  • Figure 31: Europe Hydroxychloroquine Drugs Market Attractiveness, by Distribution Channel, 2020-2030
  • Figure 32: Asia Pacific Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 33: Asia Pacific Hydroxychloroquine Drugs Market Value Share (%), by Country/Sub-region, 2019 and 2030
  • Figure 34: Asia Pacific Hydroxychloroquine Drugs Market Attractiveness, by Country/Sub-region, 2020-2030
  • Figure 35: Asia Pacific Hydroxychloroquine Drugs Market Value Share (%), by Disease Indication, 2019 and 2030
  • Figure 36: Asia Pacific Hydroxychloroquine Drugs Market Attractiveness, by Disease Indication, 2020-2030
  • Figure 37: Asia Pacific Hydroxychloroquine Drugs Market Value Share (%), by Distribution Channel, 2019 and 2030
  • Figure 38: Asia Pacific Hydroxychloroquine Drugs Market Attractiveness, by Distribution Channel, 2020-2030
  • Figure 39: Latin America Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 40: Latin America Hydroxychloroquine Drugs Market Value Share, by Country/Sub-region, 2019-2030
  • Figure 41: Latin America Hydroxychloroquine Drugs Market Attractiveness, by Country/Sub-region, 2019-2030
  • Figure 42: Latin America Hydroxychloroquine Drugs Market Value Share (%), by Disease Indication, 2019 and 2030
  • Figure 43: Latin America Hydroxychloroquine Drugs Market Attractiveness, by Disease Indication, 2020-2030
  • Figure 44: Latin America Hydroxychloroquine Drugs Market Value Share (%), by Distribution Channel, 2019 and 2030
  • Figure 45: Latin America Hydroxychloroquine Drugs Market Attractiveness, by Distribution Channel, 2020-2030
  • Figure 46: Middle East & Africa Hydroxychloroquine Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 47: Middle East & Africa Remote Patient Monitoring Devices Market Value Share, by Country/Sub-region, 2019-2030
  • Figure 48: Middle East & Africa Remote Patient Monitoring Devices Market Attractiveness, by Country/Sub-region, 2019-2030
  • Figure 49: Middle East & Africa Hydroxychloroquine Drugs Market Value Share (%), by Disease Indication, 2019 and 2030
  • Figure 50: Middle East & Africa Hydroxychloroquine Drugs Market Attractiveness, by Disease Indication, 2020-2030
  • Figure 51: Middle East & Africa Hydroxychloroquine Drugs Market Value Share (%), by Distribution Channel, 2019 and 2030
  • Figure 52: Middle East & Africa Hydroxychloroquine Drugs Market Attractiveness, by Distribution Channel, 2020-2030
  • Figure 53: Global Hydroxychloroquine Drugs Market Share Analysis, by Company, 2019